Merlin, Inc.

8-A12B effective

Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) filed a Form 8-A to register its common stock for listing on Nasdaq, effective March 17, 2026. The filing confirms the company's transition from a special purpose acquisition company (SPAC) to a standalone entity, with the stock listing following the completion of its initial public offering (IPO).

EFFECT effective

The current filing marks the effectiveness of a registration statement for a business combination involving Inflection Point Acquisition Corp. IV (renaming to Merlin Labs, Inc.) and Merlin Labs, Inc. The transaction includes a domestication from the Cayman Islands to Delaware, a merger with Merlin Labs, and share conversions. The filing outlines the restructuring of securities, including Class A shares, rights, and units, and references a Sponsor Support Agreement for share conversions.

DRS filed

Merlin, Inc. is undergoing a business combination involving Bleichroeder Acquisition Corp. I, resulting in a jurisdiction change from the Cayman Islands to Delaware. The transaction includes share conversions, warrant exchanges, and a name change to 'Merlin Labs, Inc.' The filing outlines the merger structure, securities conversion ratios, and regulatory compliance steps, with the offering subject to the completion of the business combination.

424B4 priced

Merlin, Inc. (Bleichroeder Acquisition Corp. I) is conducting an IPO of 25,000,000 units at $10.00 per unit, with underwriters' over-allotment options. The filing details redemption rights for public shareholders, a private placement of 425,000 units by the sponsor, and structure of founder shares convertible to Class A shares. The company has 24 months to complete an initial business combination, with liquidation provisions if unsuccessful. Securities are registered for Nasdaq listing under symbols 'BACQU', 'BACQ', and 'BACQR'.

EFFECT effective

The filing confirms the effectiveness of Bleichroeder Acquisition Corp. I's S-1 registration statement, enabling the company to proceed with its initial public offering (IPO). The company, a blank check entity, aims to pursue a business combination through a merger, acquisition, or similar transaction. The IPO involves 25,000,000 units at $10.00 per unit, with a private placement of 425,000 units by the sponsor and Inflection Point Fund I LP. Shareholders have redemption rights for public shares upon completion of an initial business combination.

8-A12B effective

Bleichroeder Acquisition Corp. I filed Form 8-A to register units, Class A ordinary shares, and rights to receive Class A shares on The Nasdaq Stock Market LLC. The filing incorporates by reference the prospectus from its prior S-1 registration statement (File No. 333-280777), which was declared effective on October 31, 2024. The securities include units composed of one Class A share and one right, with the rights entitling holders to 1/10 of a Class A share.

S-1/A amended

Bleichroeder Acquisition Corp. I, a Cayman Islands exempted company, is conducting an IPO to raise $250 million through the sale of 25 million units. The company aims to complete a business combination within 24 months but has not yet selected a target. The offering includes Class A shares and share rights, with redemption rights for public shareholders. The sponsor, Bleichroeder Sponsor 1 LLC, has committed to a private placement, and Inflection Point Fund I LP has expressed interest in purchasing private placement units. The filing highlights risks related to conflicts of interest, redemption limitations, and the potential for founder shares to expire worthless.

S-1/A amended

Merlin, Inc. (Bleichroeder Acquisition Corp. I) is a blank check company formed to pursue a business combination, with an initial public offering of 25,000,000 units at $10.00 each. The current filing updates the unit structure from warrants to share rights, clarifies redemption rights for public shareholders, and details sponsor commitments, including a private placement of units by Bleichroeder Sponsor 1 LLC and potential involvement of Inflection Point Fund I LP. The company has 24 months to complete its initial business combination, with risks related to conflicts of interest, redemption limitations, and potential loss of investment if the combination fails.

S-1/A amended

Bleichroeder Acquisition Corp. I, a Cayman Islands exempted company, is conducting an IPO to raise $250 million through the sale of 25 million units, each consisting of one Class A share and a quarter of a redeemable warrant. The company has not yet identified a business combination target and aims to complete an acquisition within 24 months (extendable to 27 months under certain conditions). Public shareholders have redemption rights upon completion of a business combination, and the sponsor has committed to purchasing additional warrants. The filing includes updated terms regarding redemption limitations, sponsor share conversions, and extended timelines for business combination completion.

S-1 filed

Bleichroeder Acquisition Corp. I, a Cayman Islands exempted company, is conducting an IPO to raise $250 million through the sale of 25 million units at $10.00 each. Each unit includes one Class A share and a quarter of a redeemable warrant. The company has not yet identified a target for a business combination and aims to complete such a transaction within 24 months (or 27 months if a letter of intent is in place). Public shareholders will have redemption rights for their shares upon completion of a business combination. The sponsor has committed to a private placement of 2 million warrants. The offering includes risks related to conflicts of interest, dilution, and the company's dependence on a single business combination.